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Conventional wisdom suggests that 
when pulmonary dendritic cells (DCs) 
are  activated  by  influenza  infection, 
they  phagocytose  local  antigens  and 
migrate  to  the  draining  lymph  node 
(LN).  Once  in  the  LN,  they  either 
present  antigen  directly  (Ballesteros-
Tato et al., 2010) or hand off antigen 
to LN-resident DCs (Belz et al., 2004), 
which  then  present  antigen  to  naive 
CD8 T cells. Effective antigen presen-
tation  leads  to  the  activation,  prolif-
eration, and differentiation of effector 
CD8 T cells, which then migrate to 
the  lung  and  kill  influenza-infected 
epithelial  cells.  However,  more  re-
cent studies show that pulmonary DCs 
are also important in the lung itself to 
maintain CD8 T cell effectors (McGill 
et al., 2008). In fact, mice depleted of 
pulmonary (but not systemic) DCs via 
intranasally delivered chlodronate-filled 
liposomes are unable to maintain CD8 
T cell responses in the lung and do not 
effectively clear influenza virus (McGill 
et al., 2008). Thus, influenza-specific 
effector CD8 T cells require continued 
stimulation from DCs, even after the T 
cells have arrived in the lung.
In  this  issue,  McGill  et  al.  build 
on these findings and show that CD8 
T cells continue to proliferate in the 
lungs  of  influenza-infected  mice,  re-
gardless  of  whether  pulmonary  DCs 
are depleted or not (McGill et al., 2010). 
However, despite normal rates of pro-
liferation in DC-depleted mice, the 
numbers of CD8 T cells in the lungs 
are  down  and  the  markers  of  apop-
tosis are up. CD8 T cell numbers are 
restored  and  apoptosis  is  reversed  by 
intranasal  reconstitution  with  pulmo-
nary DCs, implicating DCs in the lo-
cal survival of CD8 T cells in the lung. 
Importantly, the transferred DCs must 
present  antigen  and  trans-present  in-
terleukin-15  (IL-15)  to  restore  the 
pulmonary CD8 T cell response.
Although IL-15 is known to play 
a role in the maintenance of memory 
CD8 T cells (Schluns and Lefrançois, 
2003; Surh et al., 2006), the ability of 
IL-15 to support the survival of effec-
tor CD8 T cells is not well appreci-
ated. Nevertheless, the results reported 
here are consistent with previous data 
showing  that  the  administration  of 
exogenous  IL-15  to  mycobacteria-
infected  mice  up-regulates  Bcl-2  ex-
pression and inhibits the apoptosis of 
effector CD8 T cells in the lung (Tang 
et al., 2009). Similar studies suggest that 
IL-15 promotes the survival of a sub-
set of KLRG-1
+CD27
 CD8 T cells, 
which are thought to represent short-
lived  effectors  (Stonier  et  al.,  2008). 
IL-15  is  also  important  for  the  sur-
vival  of  Listeria  monocytogenes–specific 
CD44
+CD62L
CD127
 effector CD8 
T cells during the contraction phase of 
the CD8 T cell response (Yajima et al., 
2006).  Given  the  finding  that  deple-
tion of pulmonary DCs leads to poor 
viral clearance (McGill et al., 2008), it 
is tempting to speculate that the ab-
sence  of  IL-15–presenting  DCs  leads 
to poor CD8 T cell effector activity in 
the lung. However, direct evidence that 
IL-15 maintains functional CD8 T cell 
effectors, rather than simply promoting 
CD8 T cell survival during the transi-
tion from effector to memory cells, is 
lacking.
The identity of the cells that trans-
present IL-15 to CD8 T cells is also 
somewhat controversial. Some studies 
show that expression of the IL-15R on 
macrophages, but not on DCs, supports 
the early transition of antigen-specific 
effector CD8 T cells to memory cells 
(Mortier  et  al.,  2009).  However,  the 
expression of IL-15R on DCs selec-
tively maintains central memory CD8 
T cells, whereas the expression of the 
IL-15R on macrophages supports both 
central  and  effector  memory  CD8 T 
cells (Mortier et al., 2009). Other stud-
ies also suggest that DCs are important 
for the maintenance of memory CD8 
T cells, but indicate that DCs are not 
the  only  cell  type  involved  in  IL-15   
trans-presentation (Stonier et al., 2008). 
Importantly,  McGill  et  al.  (2010)  go 
beyond  just  differentiating  between 
DCs and macrophages; they find that 
both  plasmacytoid  DCs  (pDCs)  and 
CD8
+ (CD8 DCs) pulmonary DCs 
make  IL-15,  as  do  alveolar  macro-
phages. Moreover, these same popula-
tions express similar levels of IL-15R. 
However, pDCs and CD8 DCs, but 
not macrophages, were able to rescue 
the CD8 T cell response upon adop-
tive  transfer  into  mice  depleted  of 
pulmonary DCs (McGill et al., 2008). 
Thus, the authors conclude that IL-15   
is  produced  and  trans-presented  by 
both  pDCs  and  CD8  DCs  in  the 
lung  during  influenza  infection,  that 
these  same  DCs  present  antigen,  and 
The phrase “think globally, act locally” was coined in the early 1970s and 
directed individuals to clean up their local environment with the ultimate 
goal of improving the health of the entire planet. Several recent studies 
indicate that similar considerations apply to the immune system, in which 
small numbers of leukocytes, such as pulmonary dendritic cells, can modify 
the local immune environment in the lung and promote a positive outcome 
for the organism.
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cell follicles surrounded by DCs and 
some  T  cells  (Fig.  1).  Importantly, 
iBALT areas disappear upon depletion 
of pulmonary DCs, suggesting that DCs 
are somehow responsible for the main-
tenance  of  iBALT  (GeurtsvanKessel   
et al., 2009). Similarly, Halle et al. find 
that  modified  vaccinia  Ankara  infec-
tion of the lungs leads to the progres-
sive  development  of  iBALT  (Halle   
et al., 2009). Again, the maintenance of 
iBALT is dependent on CD11c
+ cells, 
as diptheria toxin (DT)–mediated de-
pletion of CD11c
+ cells from the lungs 
of infected mice leads to the rapid dis-
solution of iBALT. Without interven-
tion,  iBALT  areas  are  maintained  for 
lymphoid  tissues  called  inducible 
bronchus-associated  lymphoid  tissue 
(iBALT) that develop in the lungs after 
infection (Moyron-Quiroz et al., 2004; 
McGill et al., 2008).
Two  recent  studies  (Geurtsvan-
Kessel et al., 2009; Halle et al., 2009) 
indicate that pulmonary DCs are im-
portant for the maintenance and func-
tion of iBALT. GeurtsvanKessel et al. 
show  that  CD11b
hiMHCII
hi  DCs  ac-
cumulate  in  the  lungs  after  influenza 
infection  and  continue  to  increase  in 
numbers, even after infection is cleared 
  (GeurtsvanKessel et al., 2009). This in-
crease correlates with the formation of 
iBALT areas, which contain central B 
that both functions are required for ro-
bust effector CD8 T cell responses in 
the lung.
A question not addressed by McGill 
et al. (2010) is where pulmonary DCs 
present antigen and IL-15 to effector 
CD8 T cells. One possibility is that pul-
monary DCs present antigen and IL-15 
in the airways (Fig. 1). However, CD8 
T cells in the airways lose expression of 
IL-15R and do not respond to IL-15, 
suggesting that DCs do not promote the 
survival of CD8 T cells in the airways 
(Shen et al., 2008). Another possibility 
is that pulmonary DCs continue to mi-
grate to the draining LN, where they 
present antigen and IL-15 throughout 
the  course  of  infection  and  maintain 
the production of CD8 effector T cells. 
Although some work suggests that the 
initial presentation of influenza antigens 
occurs in the LN during the first 48 h   
after  infection  and  that  antigen  pre-
sentation shifts exclusively to the lung 
after that (Legge and Braciale, 2003), 
more recent work suggests that DCs 
continue  to migrate to the LN from 
the lung for many days after infection 
and that peak migration occurs around 
day  5  (Ballesteros-Tato  et  al.,  2010). 
Moreover, pulmonary DCs adoptively 
transferred to the lungs of influenza-
infected mice 5 d after infection migrate 
to the LN within 24 h. These migratory 
DCs include CD103
+CD11b
lo epithe-
lial  DCs,  as  well  as  CD103
CD11b
hi 
parenchymal  DCs  (Ballesteros-Tato   
et al., 2010), both of which express low 
levels of CD8 and may correspond to 
the IL-15–presenting CD8 DCs de-
scribed above.
A third possibility, and the one fa-
vored by McGill et al. (2010), is that 
DCs present antigen in situ in the lung, 
presumably  in  the  parenchyma.  This 
possibility  is  supported  by  previous 
data showing that antigen presentation 
to CD4 and CD8 T cells can occur in 
the lung in the absence of conventional 
lymphoid tissues (Constant et al., 2002; 
Moyron-Quiroz et al., 2004, 2006). If 
DCs can interact with T cells directly 
in the lung, where do these interactions   
take  place?  McGill  et  al.  previously   
speculated  that  local  antigen  presen-
tation in the lung may occur in local   
Figure 1.  DCs facilitate lymphocyte recruitment, organization, and activation in the lung 
via multiple mechanisms. DCs may promote the survival and expansion of antigen-specific effector 
CD8 T cells in the lung by producing IL-15 and presenting antigen. This could occur either in the 
airways or in lung parenchyma, particularly in areas of iBALT. DCs may also promote the expansion 
or survival of plasma cells in the lung by producing IL-6 and APRIL. DCs may also indirectly affect 
lymphocyte activities by triggering differentiation of high endothelial venules (HEVs) or stromal cells 
via the production of LT. In turn, the HEVs recruit lymphocytes into iBALT, whereas the stromal 
cells produce cytokines and chemokines that support lymphocyte survival and organization, includ-
ing the formation of germinal centers.JEM VOL. 207, March 15, 2010 453
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CXCL13 is not required for the forma-
tion of iBALT, per se, even though it 
does promote the formation of a proper 
B cell follicle (Rangel-Moreno et al., 
2007). However, LTR signaling is re-
quired for the maintenance of iBALT, 
as the administration of LTR-Ig re-
duces  the  number  of  germinal  cen-
ter B cells and the number of iBALT 
areas  in  the  lungs  (GeurtsvanKessel   
et al., 2009). Although this experiment 
shows that LTR signaling is impor-
tant  for  the  maintenance  of  iBALT, 
just as it is important for the mainte-
nance of other ectopic lymphoid tissues 
(Gatumu et al., 2009), it does not indi-
cate what cells might be the important 
source of LT. Given that the depletion 
of pulmonary DCs only modestly re-
duces LT expression and has no effect 
on either CXCL13 or CCL21 expres-
sion (GeurtsvanKessel et al., 2009), it 
seems that DCs are likely involved in 
the  maintenance  of  iBALT  via  some 
other mechanism, such as the presenta-
tion of IL-15 to CD8 T cells (McGill 
et al., 2010). Because CD8 T cells are 
essential for the maintenance of germi-
nal centers in ectopic follicles in other 
locations  (Wagner  et  al.,  1998),  they 
may also be playing a role in iBALT 
formation  and  maintenance.  Regard-
less, further experiments are needed to 
clarify the mechanisms by which DCs 
induce and maintain iBALT.
Collectively, the papers highlighted 
here  demonstrate  the  importance  of 
pulmonary DCs acting at the local level 
to modify the pulmonary environment 
in ways that facilitate local immune re-
sponses.  Although  these  data  directly 
apply  to  the  activities  of  DCs  in  the 
lung,  similar  events  are  likely  to  oc-
cur in other peripheral, nonlymphoid 
organs and to impact local immune re-
sponses in those organs.
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